(Massachusetts General Hospital) Investigators from Massachusetts General Hospital, the University of Michigan and Massachusetts Institute of Technology have developed investigational ‘machine learning’ models, specifically tailored to individual institutions, that can predict a patient’s risk of developing C. difficile much earlier than it would be diagnosed with current methods.